Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917852 · ClinicalTrials.gov registry record · NA
Evaluation of the GORE Conformable TAG® for Treatment of Traumatic Transection
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT00917852 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 51 participants.
The verdict
NCT00917852, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
TAG 08-02 is a prospective, multicenter, single-arm study to evaluate the use of the CTAG Device in traumatic transection of the descending thoracic aorta.
Interventions
- DEVICE Gore Conformable TAG Thoracic Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-11 |
| Est. Completion | 2017-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00917852
The ClinicalTrials.gov registry entry for NCT00917852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gore Conformable TAG Thoracic Endoprosthesis is the first listed.
NCT00917852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00917852 about?
NCT00917852 is a clinical study titled "Evaluation of the GORE Conformable TAG® for Treatment of Traumatic Transection". TAG 08-02 is a prospective, multicenter, single-arm study to evaluate the use of the CTAG Device in traumatic transection of the descending thoracic aorta.
What is the current status of trial NCT00917852?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2009-11. Estimated completion is 2017-02-28.
What interventions are being tested in trial NCT00917852?
The interventions under investigation include: Gore Conformable TAG Thoracic Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT00917852?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.